{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T04:48:17Z","timestamp":1792298897002,"version":"4.4.0"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:00Z","timestamp":1566432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,10,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The body of a 61-year-old man was found at his home by his wife, lying on the floor, near the bathroom, around midnight. He was known to be training for bodybuilding, using anabolic steroids. Police investigations revealed the presence of two types of tablets at home, one supposed to contain clenbuterol (0.040\u00a0mg) and the other stanozolol (10\u00a0mg). Testing the tablets revealed different dosages from what was expected, i.e., 0.073 and 11.5\u00a0mg\/tablet, for clenbuterol and stanozolol, respectively. External body examination and autopsy, which was performed the next day, revealed generalized organ congestion and lack of any traumatic injury (confirmed by radiology). Cardiomegaly, with a heart weighing 692\u00a0g, was obvious. Anatomic pathology tests did not reveal evidence of malformations, but atheromatous plaque was identified in the coronaries during complete histology investigations. Femoral blood, urine, bile, gastric contents and two strands of hair (6\u00a0cm) were collected for toxicology. These specimens were submitted to standard analyses, but also to a specific LC\u2013MS-MS method for clenbuterol and stanozolol testing. Clenbuterol was identified in all the tissues, including femoral blood (1.1\u00a0ng\/mL), urine (7.2\u00a0ng\/mL), bile (2.4\u00a0ng\/mL), gastric content (3.2\u00a0ng\/mL) and hair (23\u00a0pg\/mg). Stanozolol only tested positive in hair (11\u00a0pg\/mg). All other analyses were negative, including blood alcohol and drugs of abuse. The pathologists concluded to cardiac insufficiency with support of cardiomegaly, in a context involving repetitive abuse of anabolic drugs. This case indicates that more attention should be paid to clenbuterol, a drug widely used as a stimulant by people who want to lose weight, athletes and bodybuilding practitioners.<\/jats:p>","DOI":"10.1093\/jat\/bkz058","type":"journal-article","created":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T11:09:27Z","timestamp":1562756967000},"page":"660-665","source":"Crossref","is-referenced-by-count":28,"title":["Complete Post-mortem Investigations in a Death Involving Clenbuterol After Long-term Abuse"],"prefix":"10.1093","volume":"43","author":[{"given":"Pascal","family":"Kintz","sequence":"first","affiliation":[{"name":"X-Pertise Consulting, 42 Rue Principale, F-67206 Mittelhausbergen, France"},{"name":"Institut de M\u00e9decine L\u00e9gale, 11 Rue Humann, F-67000 Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Gheddar","sequence":"additional","affiliation":[{"name":"Institut de M\u00e9decine L\u00e9gale, 11 Rue Humann, F-67000 Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Ameline","sequence":"additional","affiliation":[{"name":"Institut de M\u00e9decine L\u00e9gale, 11 Rue Humann, F-67000 Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Dumestre-Toulet","sequence":"additional","affiliation":[{"name":"Laboratoire ToxGen, 11 Rue du Commandant Cousteau, F-33100 Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Verschoore","sequence":"additional","affiliation":[{"name":"Unit\u00e9 de Medicine L\u00e9gale, Place Am\u00e9lie Raba-L\u00e9on, F-33000 Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Comte","sequence":"additional","affiliation":[{"name":"Unit\u00e9 de Medicine L\u00e9gale, Place Am\u00e9lie Raba-L\u00e9on, F-33000 Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-S\u00e9bastien","family":"Raul","sequence":"additional","affiliation":[{"name":"Institut de M\u00e9decine L\u00e9gale, 11 Rue Humann, F-67000 Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,8,22]]},"reference":[{"key":"2019100210115489300_ref1","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/bcpt.12991","article-title":"\u00df-2 agonists as misusing drugs? Assessment of both clenbuterol- and salbutamol-related European medicines agency pharmacovigilance database reports","volume":"123","author":"Milano","year":"2018","journal-title":"Basic & Clinical Pharmacology & Toxicology"},{"key":"2019100210115489300_ref2","first-page":"1118","article-title":"Clenbuterol: a substitute for anabolic steroids","volume":"27","author":"Prather","year":"1995","journal-title":"Medicine and Science in Sports and Exercice"},{"key":"2019100210115489300_ref3","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/jat\/32.7.522","article-title":"Detection of clenbuterol in heroin users in twelve post-mortem cases at the Philadelphia medical examiner\u2019s office","volume":"32","author":"Wingert","year":"2008","journal-title":"Journal of Analytical Toxicology"},{"key":"2019100210115489300_ref4","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1080\/02652030500135102","article-title":"Food poisoning by clenbuterol in Portugal","volume":"22","author":"Barbosa","year":"2005","journal-title":"Food Additives & Contaminants"},{"key":"2019100210115489300_ref5","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jemermed.2012.02.057","article-title":"Myocrdial ischemia associated with clenbuterol abuse: report of two cases","volume":"44","author":"Huckins","year":"2013","journal-title":"The Journal of Emergency Medicine"},{"key":"2019100210115489300_ref6","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.jemermed.2015.09.006","article-title":"Rhabdomyolisis secondary to clenbuterol use and exercice","volume":"50","author":"Grimmer","year":"2016","journal-title":"The Journal of Emergency Medicine"},{"key":"2019100210115489300_ref7","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/BF03160909","article-title":"Acute clenbuterol overdose resulting in supraventricular tachycardia and atrial fibrillation","volume":"3","author":"Daubert","year":"2007","journal-title":"Journal of Medical Toxicology"},{"key":"2019100210115489300_ref8","author":"World Anti-Doping Agency"},{"key":"2019100210115489300_ref9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jccase.2013.07.004","article-title":"Case report and review of clenbuterol cardiac toxicity","volume":"8","author":"Barry","year":"2013","journal-title":"Journal of Cardiology Cases"},{"key":"2019100210115489300_ref10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ancard.2018.08.015","article-title":"Cardiovascular complications of doping products","volume":"67","author":"Demoulin","year":"2018","journal-title":"Annales de Cardiologie et d\u2019Ang\u00e9iologie"},{"key":"2019100210115489300_ref11","first-page":"bcr2016215157","article-title":"Case of low dose clenbuterol toxicity","volume":"2016","author":"Waight","year":"2016","journal-title":"Britisch Medical Journal Case Reports"},{"key":"2019100210115489300_ref12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jemermed.2016.05.047","article-title":"A case series of clenbuterol toxicity caused by adulterated heroin","volume":"51","author":"Hieger","year":"2016","journal-title":"The Journal of Emergency Medicine"},{"key":"2019100210115489300_ref13","article-title":"L\u2019ANSM alerte sur les risques pour la sant\u00e9 des produits \u00e0 vis\u00e9e anabolisante ou amaigrissante CLENOX\u00ae et STANOX-10\u00ae de Pacific Pharmaceutical Company LTD. Malay Tiger, vendus sur internet-Point d\u2019information.","author":"ANSM"},{"key":"2019100210115489300_ref14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0378-4347(00)00137-7","article-title":"Testing of the anabolic stanozolol in human hair by gas chromatography-negative ion chemical ionization mass spectrometry","volume":"740","author":"Cirimele","year":"2000","journal-title":"Journal of Chromatography B Biomedical Science Applications"},{"key":"2019100210115489300_ref15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1248\/bpb1978.8.385","article-title":"Pharmacokinetics of plasma and urine clenbuterol in man, rat, and rabbit","volume":"8","author":"Yamamoto","year":"1985","journal-title":"Journal of Pharmacobiodynamy"},{"key":"2019100210115489300_ref16","doi-asserted-by":"crossref","first-page":"1739.e5","DOI":"10.1016\/j.ajem.2015.12.086","article-title":"Clenbuterol causing non-ST-segment elevation myocarial infarction in a teenage female desinring to lose weight: case and brief literature review","volume":"34","author":"Quinley","year":"2016","journal-title":"The American Journal of Emergency Medicine"},{"key":"2019100210115489300_ref17","doi-asserted-by":"crossref","first-page":"454","DOI":"10.2527\/1997.752454x","article-title":"Distribution, elimination, and residues of [14C] clenbuterol HCl in Holstein calves","volume":"75","author":"Smith","year":"1997","journal-title":"Journal of Animal Science"},{"key":"2019100210115489300_ref18","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/dta.1746","article-title":"Statistical difference of hair analysis of clenbuterol to discriminate therapeutic use from contamination","volume":"6","author":"Krumbholtz","year":"2014","journal-title":"Drug testing and Analysis"},{"key":"2019100210115489300_ref19","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1520\/JFS15228J","article-title":"Hair analysis of seven bodybuilders for anabolic steroids, ephedrine and clenbuterol","volume":"47","author":"Dumestre-Toulet","year":"2002","journal-title":"Journal of Forensic Science"},{"key":"2019100210115489300_ref20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0379-0738(99)00024-9","article-title":"Testing for anabolic steroids in hair from two bodybuilders","volume":"101","author":"Kintz","year":"1999","journal-title":"Forensic Science International"},{"key":"2019100210115489300_ref21","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.toxac.2017.05.003","article-title":"A new series of hair test results involving anabolic steroids","volume":"29","author":"Kintz","year":"2017","journal-title":"Toxicologie Analytique et Clinique"},{"key":"2019100210115489300_ref22","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/00007611-199808000-00019","article-title":"Clenbuterol and anabolic steroids: a previous unreported cause of myocardial infarction with normal coronary arteriograms","volume":"91","author":"Goldstein","year":"1998","journal-title":"South Medical Journal"},{"key":"2019100210115489300_ref23","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1177\/1557988318783504","article-title":"Performance-enhancing drugs abuse caused cardiomyopathy and acute hepatic injury in a young bodybuilder","volume":"12","author":"Li","year":"2018","journal-title":"American Journal of Men\u2019s Health"},{"key":"2019100210115489300_ref24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/clc.4960190216","article-title":"Manifestation of severe coronary heart disease after anabolic drug abuse","volume":"19","author":"Mewis","year":"1996","journal-title":"Clinical Cardiology"}],"container-title":["Journal of Analytical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jat\/advance-article-pdf\/doi\/10.1093\/jat\/bkz058\/29197703\/bkz058.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jat\/article-pdf\/43\/8\/660\/30095506\/bkz058.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T14:12:02Z","timestamp":1570025522000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jat\/article\/43\/8\/660\/5553030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,22]]},"references-count":24,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,8,22]]},"published-print":{"date-parts":[[2019,10,10]]}},"URL":"https:\/\/doi.org\/10.1093\/jat\/bkz058","relation":{},"ISSN":["0146-4760","1945-2403"],"issn-type":[{"value":"0146-4760","type":"print"},{"value":"1945-2403","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,10]]},"published":{"date-parts":[[2019,8,22]]}}}